A carregar...
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
An accurate and early diagnosis of Alzheimer’s disease (AD) is important to select optimal patient care and is critical in current clinical trials targeting core AD neuropathological features. The past decades, much progress has been made in the development and validation of cerebrospinal fluid (CSF...
Na minha lista:
| Publicado no: | J Alzheimers Dis |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IOS Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5870045/ https://ncbi.nlm.nih.gov/pubmed/29562530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170680 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|